1. "New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy. Issue 1 (December 2015) Authors: Twelves, Christopher; Cortes, Javier; Kaufman, Peter; Yelle, Louise; Awada, Ahmad; Binder, Terri; Olivo, Martin; Song, James; O'Shaughnessy, Joyce; Jove, Maria; Perez, Edith Journal: Breast cancer research Issue: Volume 17:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer. Issue 1 (2nd January 2021) Authors: El Hachem, Georges; Gombos, Andrea; Awada, Ahmad Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 1(2021) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advances in chemical pharmacotherapy to manage advanced breast cancer. (2nd January 2017) Authors: Gombos, Andrea; Awada, Ahmad Journal: Expert opinion on pharmacotherapy Issue: Volume 18:Number 1(2017) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An open-label, dose-escalation study to evaluate the safety and pharmacokinetics of CEP-9722 (a PARP-1 and PARP-2 inhibitor) in combination with gemcitabine and cisplatin in patients with advanced solid tumors. Issue 4 (April 2016) Authors: Awada, Ahmad; Campone, Mario; Varga, Andrea; Aftimos, Philippe; Frenel, Jean-Sébastien; Bahleda, Rastilav; Gombos, Andrea; Bourbouloux, Emmanuelle; Soria, Jean-Charles Journal: Anti-cancer drugs Issue: Volume 27:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Analyses of the Rationale and Implementation of Research Biopsies in Oncology Clinical Trials at a Tertiary Cancer Center. (4th August 2021) Authors: Olympios, Nathalie; Collet, Laetitia; Paesmans, Marianne; Jungels, Christiane; Kotecki, Nuria; Awada, Ahmad; Aftimos, Philippe Journal: Oncologist Issue: Volume 26:Number 12(2021) Page Start: 1062 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics. (3rd July 2021) Authors: Saini, Kamal S; Punie, Kevin; Twelves, Chris; Bortini, Stefanella; de Azambuja, Evandro; Anderson, Steven; Criscitiello, Carmen; Awada, Ahmad; Loi, Sherene Journal: Expert opinion on biological therapy Issue: Volume 21:Number 7(2021) Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment. (December 2020) Authors: Subbiah, Vivek; Paz-Ares, Luis; Besse, Benjamin; Moreno, Victor; Peters, Solange; Sala, María Angeles; López-Vilariño, José Antonio; Fernández, Cristian; Kahatt, Carmen; Alfaro, Vicente; Siguero, Mariano; Zeaiter, Ali; Zaman, Khalil; López, Rafael; Ponce, Santiago; Boni, Valentina; Arrondeau, Jen... Journal: Lung cancer Issue: Volume 150(2020) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. (January 2022) Authors: Awada, Ahmad; Berghmans, Thierry; Clement, Paul M.; Cuppens, Kristof; De Wilde, Bram; Machiels, Jean-Pascal; Pauwels, Patrick; Peeters, Marc; Rottey, Sylvie; Van Cutsem, Eric Journal: Critical reviews in oncology/hematology Issue: Volume 169(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort. Issue 2 (7th July 2020) Authors: Cho, Byoung Chul; Daste, Amaury; Ravaud, Alain; Salas, Sébastien; Isambert, Nicolas; McClay, Edward; Awada, Ahmad; Borel, Christian; Ojalvo, Laureen S; Helwig, Christoph; Rolfe, P Alexander; Gulley, James L; Penel, Nicolas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort. Issue 2 (7th July 2020) Authors: Cho, Byoung Chul; Daste, Amaury; Ravaud, Alain; Salas, Sébastien; Isambert, Nicolas; McClay, Edward; Awada, Ahmad; Borel, Christian; Ojalvo, Laureen S; Helwig, Christoph; Rolfe, P Alexander; Gulley, James L; Penel, Nicolas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗